Use of OKT3 in kidney, pancreas, and liver transplantation.
D'Alessandro
A M
AM
Department of Surgery, University of Wisconsin Hospital, Madison 53792.
Pirsch
J D
JD
Melzer
J S
JS
Sollinger
H W
HW
Kalayoglu
M
M
Reed
A
A
Knechtle
S J
SJ
Belzer
F O
FO
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003524:Cyclosporins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D016031:Liver Transplantation / Q000276:immunology*; D016853:Muromonab-CD3; D016035:Pancreas Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D003524:Cyclosporins; D016853:Muromonab-CD3; D001379:Azathioprine; D011241:Prednisone